FLORHAM PARK, N.J. — Hisamitsu America, a division of Hisamitsu Pharmaceutical Co. Inc. and the manufacturers of Salonpas, an OTC pain patch that is FDA approved and clinically proven, last week announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.
"Transdermal creams, gels, foam and patches offer a unique way of delivering medication to your body, which offers significant advantages over taking medications orally," says Dr. Sylvia Hesse, who is an orthopedic medicine specialist at Manhattan Spine and Sports Medicine." One of the biggest advantages is that the medication is delivered directly to the site of pain. Direct application allows a higher concentration of the drug to reach the tissue that needs it. The total amount of medication absorbed into the bloodstream is low, leading to a very low incidence of side effects in contrast to oral medications. Topical treatments can use less medicine and get the same or better relief."
"While many Americans still turn to over-the-counter pills to relieve pain, topical analgesic pain relief is gaining market recognition and we are proud to bring to market solutions that are well-tested and manufactured to the highest quality," said John Incledon, president and CEO of Hisamitsu America.
Designed to penetrate deep to relieve the toughest muscle and joint pain, Salonpas Deep Relieving Gel is an easy-to-use topical analgesic that starts to deliver pain relief in seconds, the company noted. With three active ingredients, camphor (3.1%), menthol (10%) and methyl salicylate (15%), Deep Relieving Gel rushes strong medicine where you need it in a fast-melting, quick-absorbing, clear, non-greasy formula.
New Salonpas Deep Relieving Gel is available at leading retailers nationwide.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.